Many customers are interested in the company's products, especially in #orthopaedic products, a large number of customers show strong intention to cooperate, anti-adhesion and #ophthalmology also have customer concern, #hemostatic powder is highly expected, customers are highly professional, the exhibition effect is very good.
25th EXPOMED EURASIA BROKE A RECORD!
Expomed Eurasia, the most important meeting platform for the medical industry across Eurasia and Turkey, was held between March 22-25, 2018 at Tüyap Fair and Congress Center The fair, attracting a total of 35,832 sector professionals including 6,104 international visitors from 90 countries, got full marks from the participants.
Find Your New Business & Solutions Partners at This Show
With 23% more international visitors and 20% more exhibiting companies compared to 2017 Expomed Eurasia is now the business platform for medical sector. The show makes Istanbul the heart of medical industry for four days allowing all exhibitors and visitors all across the world a great networking opportunity.
-
singclean | 2018-03-29Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world.
-
singclean | 2018-03-29Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
-
singclean | 2018-03-29Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen